Green Tea Epigallocatechin-3-Gallate (EGCG) Modulates Amyloid Precursor Protein Cleavage and Reduces Cerebral Amyloidosis in Alzheimer Transgenic Mice

Alzheimer's disease (AD) is a progressive neurodegenerative disorder pathologically characterized by deposition of β-amyloid (Aβ) peptides as senile plaques in the brain. Recent studies suggest that green tea flavonoids may be used for the prevention and treatment of a variety of neurodegenerative diseases. Here, we report that (-)-epigallocatechin-3-gallate (EGCG), the main polyphenolic constituent of green tea, reduces Aβ generation in both murine neuron-like cells (N2a) transfected with the human “Swedish” mutant amyloid precursor protein (APP) and in primary neurons derived from Swedish mutant APP-overexpressing mice (Tg APPsw line 2576). In concert with these observations, we find that EGCG markedly promotes cleavage of the α-C-terminal fragment of APP and elevates the N-terminal APP cleavage product, soluble APP-α. These cleavage events are associated with elevated α-secretase activity and enhanced hydrolysis of tumor necrosis factor α-converting enzyme, a primary candidate α-secretase. As a validation of these findings in vivo, we treated Tg APPsw transgenic mice overproducing Aβ with EGCG and found decreased Aβ levels and plaques associated with promotion of the nonamyloidogenic α-secretase proteolytic pathway. These data raise the possibility that EGCG dietary supplementation may provide effective prophylaxis for AD.

[1]  N. Hooper,et al.  ADAMs family members as amyloid precursor protein alpha-secretases. , 2003, Journal of neuroscience research.

[2]  R. Motter,et al.  Amyloid precursor protein processing and Aβ42 deposition in a transgenic mouse model of Alzheimer disease , 1997 .

[3]  J. Girault,et al.  A Single Ascending Dose Study of Epigallocatechin Gallate in Healthy Volunteers , 2003, The Journal of international medical research.

[4]  S. Younkin,et al.  Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.

[5]  P. Shah,et al.  Differential Effects of Green Tea–Derived Catechin on Developing Versus Established Atherosclerosis in Apolipoprotein E–Null Mice , 2004, Circulation.

[6]  J. Launay,et al.  Regulation of the amyloid precursor protein ectodomain shedding by the 5‐HT4 receptor and Epac , 2005, FEBS letters.

[7]  P. Kloetzel,et al.  Green Tea Epigallocatechin-3-Gallate Mediates T Cellular NF-κB Inhibition and Exerts Neuroprotection in Autoimmune Encephalomyelitis1 , 2004, The Journal of Immunology.

[8]  L. Ma,et al.  Constitutive shedding of the amyloid precursor protein ectodomain is up-regulated by tumour necrosis factor-alpha converting enzyme. , 2001, The Biochemical journal.

[9]  I. Lieberburg,et al.  Cellular mechanisms of beta-amyloid production and secretion. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[10]  G. Siegel,et al.  Intracerebroventricular passive immunization with anti‐Aβ antibody in Tg2576 , 2003, Journal of neuroscience research.

[11]  S. Younkin,et al.  Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease. , 2000, Biochimica et biophysica acta.

[12]  M. Kliot,et al.  Endocannabinoids accumulate in spinal cord of SOD1G93A transgenic mice , 2004, Journal of neurochemistry.

[13]  D. Skovronsky,et al.  Neuronal localization of the TNFalpha converting enzyme (TACE) in brain tissue and its correlation to amyloid plaques. , 2001, Journal of neurobiology.

[14]  N. Hooper,et al.  The search for alpha-secretase and its potential as a therapeutic approach to Alzheimer s disease. , 2002, Current medicinal chemistry.

[15]  V. Goldberg,et al.  Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1 beta-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes. , 2002, Free radical biology & medicine.

[16]  C. R. Herzog,et al.  Tea and cancer prevention: studies in animals and humans. , 2003, The Journal of nutrition.

[17]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[18]  Yona Levites,et al.  Involvement of Protein Kinase C Activation and Cell Survival/ Cell Cycle Genes in Green Tea Polyphenol (−)-Epigallocatechin 3-Gallate Neuroprotective Action* , 2002, The Journal of Biological Chemistry.

[19]  R. Tanzi,et al.  Inhibitors of beta-amyloid formation based on the beta-secretase cleavage site. , 2000, Biochemical and biophysical research communications.

[20]  A. Turner,et al.  The Search for α-Secretase and its Potential as a Therapeutic Approach to Alzheimer's Disease , 2002 .

[21]  W. Le,et al.  (−)‐Epigallocatechin gallate inhibits lipopolysaccharide‐induced microglial activation and protects against inflammation‐mediated dopaminergic neuronal injury , 2004, Journal of neuroscience research.

[22]  H. Fujiki,et al.  Mechanisms of cancer prevention by tea polyphenols based on inhibition of TNF-α expression , 2000 .

[23]  Myung-Kwan Han.  Epigallocatechin gallate, a constituent of green tea, suppresses cytokine-induced pancreatic β-cell damage , 2003, Experimental & Molecular Medicine.

[24]  Nigel H. Greig,et al.  Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer’s disease , 2002, NeuroMolecular Medicine.

[25]  Nagi B. Kumar,et al.  Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials. , 2004, Nutrition reviews.

[26]  Hugo Vanderstichele,et al.  Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein , 1998, Nature.

[27]  K. Bae,et al.  Green tea catechins as a BACE1 (β-secretase) inhibitor , 2003 .

[28]  Y. Ihara,et al.  Truncated Carboxyl-Terminal Fragments of β-Amyloid Precursor Protein Are Processed to Amyloid β-Proteins 40 and 42† , 2004 .

[29]  L. Refolo,et al.  Amyloid precursor protein compartmentalization restricts beta-amyloid production: therapeutic targets based on BACE compartmentalization. , 2004, Journal of molecular neuroscience : MN.

[30]  R. Tanzi,et al.  Inhibitors of β-Amyloid Formation Based on the β-Secretase Cleavage Site , 2000 .

[31]  J. Lin,et al.  Cancer chemoprevention by tea polyphenols. , 2000, Proceedings of the National Science Council, Republic of China. Part B, Life sciences.

[32]  D. Alberts,et al.  Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[33]  R. Flavell,et al.  Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice , 2002, Nature Neuroscience.

[34]  Alfredo G. Tomasselli,et al.  Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity , 1999, Nature.

[35]  O. Hurtado,et al.  Expression and function of tumour necrosis factor-alpha-converting enzyme in the central nervous system. , 2003, Neuro-Signals.

[36]  K. Bae,et al.  Green tea catechins as a BACE1 (beta-secretase) inhibitor. , 2003, Bioorganic & medicinal chemistry letters.

[37]  Sri Nabawiyati nurul Makiyah.  Cell Signaling Pathways in the Neuroprotective Actions of the Green Tea Polyphenol (-)-epigallocatechin-3-gallate: Implications for Neurodegenerative Diseases , 2005 .

[38]  V. Bigl,et al.  Constitutive overactivation of protein kinase C in guinea pig brain increases α‐secretory APP processing without decreasing β‐amyloid generation , 2000 .

[39]  R. Doms,et al.  Closing in on the amyloid cascade: recent insights into the cell biology of Alzheimer's disease. , 2000, Molecular neurobiology.

[40]  H. Fujiki,et al.  Mechanisms of cancer prevention by tea polyphenols based on inhibition of TNF-alpha expression. , 2000, BioFactors.

[41]  V. Bigl,et al.  Constitutive overactivation of protein kinase C in guinea pig brain increases alpha-secretory APP processing without decreasing beta-amyloid generation. , 2000, The European journal of neuroscience.

[42]  S. Lincoln,et al.  A Loss of Function Mutation of Presenilin-2 Interferes with Amyloid β-Peptide Production and Notch Signaling* , 1999, The Journal of Biological Chemistry.

[43]  S. Younkin,et al.  Biochemical detection of Aβ isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer’s disease , 2000 .

[44]  N. Hooper,et al.  ADAMs family members as amyloid precursor protein α‐secretases , 2003 .

[45]  S. Mandel,et al.  Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (‐)‐epigallocatechin‐3‐gallate: implications for neurodegenerative diseases , 2004 .

[46]  O. Hurtado,et al.  Expression and Function of Tumour Necrosis Factor-α-Converting Enzyme in the Central Nervous System , 2003, Neurosignals.

[47]  S. Mandel,et al.  Neuroprotection and neurorescue against Aβ toxicity and PKC‐dependent release of non‐amyloidogenic soluble precursor protein by green tea polyphenol (‐)‐epigallocatechin‐3‐gallate , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[48]  Y. Ihara,et al.  Truncated carboxyl-terminal fragments of beta-amyloid precursor protein are processed to amyloid beta-proteins 40 and 42. , 2004, Biochemistry.